Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-12-02T21:21:05.417Z Has data issue: false hasContentIssue false

P02.320 Safety and effectiveness of olanzapine versus typical antipsychotic drugs in the treatment of inpatients with schizophrenia (Europa study)

Published online by Cambridge University Press:  16 April 2020

J.C. Gomez
Affiliation:
EUROPA, Lilly S.A. Madrid. Spain, SO Aparlado de Correos 585, 2808Madrid, Spain
J.A. Sacristan
Affiliation:
EUROPA, Lilly S.A. Madrid. Spain, SO Aparlado de Correos 585, 2808Madrid, Spain
P.R. Carrasco
Affiliation:
EUROPA, Lilly S.A. Madrid. Spain, SO Aparlado de Correos 585, 2808Madrid, Spain
E. Alvarez
Affiliation:
EUROPA, Lilly S.A. Madrid. Spain, SO Aparlado de Correos 585, 2808Madrid, Spain
J. Bobes
Affiliation:
EUROPA, Lilly S.A. Madrid. Spain, SO Aparlado de Correos 585, 2808Madrid, Spain
F. Cañas
Affiliation:
EUROPA, Lilly S.A. Madrid. Spain, SO Aparlado de Correos 585, 2808Madrid, Spain
J. Gascon
Affiliation:
EUROPA, Lilly S.A. Madrid. Spain, SO Aparlado de Correos 585, 2808Madrid, Spain
J. Gibert
Affiliation:
EUROPA, Lilly S.A. Madrid. Spain, SO Aparlado de Correos 585, 2808Madrid, Spain
M. Gutierrez
Affiliation:
EUROPA, Lilly S.A. Madrid. Spain, SO Aparlado de Correos 585, 2808Madrid, Spain

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposia
Copyright
Copyright © European Psychiatric Association 2000
Submit a response

Comments

No Comments have been published for this article.